Biotech scale-up (anonymized)
2022–2024 · Raised 35M EUR Series B, grant + equity structure.
Interim CFO
About the expert
Financing R&D projects in biotech and medtech. Familiar with FDA/EMA regulations and innovation funding models.
Selected missions
MedTech (anonymized)
2020–2021 · Prepared the company for due diligence by a global fund.
Competences
R&D financingGrant managementFDA/EMA complianceM&A pharmaTransfer pricingSR&ED tax credits